During the past decade, Miedziowe Centrum Zdrowia conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Miedziowe Centrum Zdrowia" #1 sponsor was "Biotronik AG" with 3 trials, followed by "Medical University of Silesia" with 3 trials sponsored, "Agennix" with 1 trials sponsored, "Cardior Pharmaceuticals GmbH" with 1 trials sponsored and "Concept Medical Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Miedziowe Centrum Zdrowia" #1 collaborator was "Cardialysis B.V." with 1 trials as a collaborator, "European Cardiovascular Research Center" with 1 trials as a collaborator, "GENELYTICA Sp. z o.o." with 1 trials as a collaborator, "Terumo Medical Corporation" with 1 trials as a collaborator and "University of Bern" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Miedziowe Centrum Zdrowia" are "Coronary Artery Disease" (8 trials), "Acute Coronary Syndrome" (1 trials), "Acute Myocardial Infarction" (1 trials), "Coronary Artery Calcification" (1 trials) and "Coronary Artery Lesion" (1 trials). Many other conditions were trialed in "Miedziowe Centrum Zdrowia" in a lesser frequency.

Most popular intervention types in "Miedziowe Centrum Zdrowia" are "Device" (9 trials), "Drug" (4 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ABSORB scaffold" (1 trials), "Abbott Laboratories Xience" (1 trials), "Abluminus DES+ Sirolimus Eluting Stent System (SES)" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Miedziowe Centrum Zdrowia" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Miedziowe Centrum Zdrowia". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Miedziowe Centrum Zdrowia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Miedziowe Centrum Zdrowia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".